Drug Type Small molecule drug |
Synonyms |
Target |
Action antagonists, inhibitors |
Mechanism H2 receptor antagonists(Histamine H2 receptor antagonists), cGMP-PDE inhibitors(3',5'-cyclic phosphodiesterase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC22H29N3O4S |
InChIKeyKMZQAVXSMUKBPD-DJWKRKHSSA-N |
CAS Registry206449-93-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Stomach Ulcer | Phase 1 | United States | 15 Apr 2016 |